Sunshine Biopharma, Inc. (SBFM)
0.243
+0.01
(+2.84%)
USD |
NASDAQ |
Oct 14, 16:00
0.2292
-0.01
(-5.68%)
After-Hours: 20:00
Sunshine Biopharma Market Cap : 0.5804M for Oct. 14, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 0.5804M |
| October 13, 2026 | 0.5644M |
| October 12, 2026 | 0.7213M |
| October 09, 2026 | 0.8068M |
| October 08, 2026 | 1.027M |
| October 07, 2026 | 1.672M |
| October 06, 2026 | 0.9504M |
| October 05, 2026 | 1.003M |
| October 02, 2026 | 1.592M |
| October 01, 2026 | 1.642M |
| September 30, 2026 | 1.846M |
| September 29, 2026 | 1.881M |
| September 28, 2026 | 1.954M |
| September 25, 2026 | 2.013M |
| September 24, 2026 | 1.911M |
| September 23, 2026 | 2.092M |
| September 22, 2026 | 2.165M |
| September 21, 2026 | 2.171M |
| September 18, 2026 | 2.149M |
| September 17, 2026 | 2.009M |
| September 16, 2026 | 2.460M |
| September 15, 2026 | 2.460M |
| September 14, 2026 | 2.556M |
| September 11, 2026 | 2.532M |
| September 10, 2026 | 2.580M |
| Date | Value |
|---|---|
| September 09, 2026 | 2.675M |
| September 08, 2026 | 2.747M |
| September 04, 2026 | 2.723M |
| September 03, 2026 | 2.651M |
| September 02, 2026 | 2.794M |
| September 01, 2026 | 2.699M |
| August 31, 2026 | 2.675M |
| August 28, 2026 | 2.747M |
| August 27, 2026 | 3.033M |
| August 26, 2026 | 2.962M |
| August 25, 2026 | 2.723M |
| August 24, 2026 | 2.771M |
| August 21, 2026 | 2.771M |
| August 20, 2026 | 2.771M |
| August 19, 2026 | 2.794M |
| August 18, 2026 | 2.675M |
| August 17, 2026 | 2.675M |
| August 14, 2026 | 2.747M |
| August 13, 2026 | 2.866M |
| August 12, 2026 | 2.890M |
| August 11, 2026 | 2.938M |
| August 10, 2026 | 0.5985M |
| August 07, 2026 | 0.6034M |
| August 06, 2026 | 0.6868M |
| August 05, 2026 | 0.6525M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.314B |
| Alnylam Pharmaceuticals, Inc. | 30.02B |
| Anika Therapeutics, Inc. | 271.01M |
| Savara, Inc. | 977.70M |
| Vericel Corp. | 2.060B |
Market Cap Related Metrics
| PS Ratio | 0.0048 |
| Price to Book Value | 0.0211 |
| Price | 0.243 |
| Earnings Yield | -4.21K% |